Clinical Trials
4
Active:0
Completed:3
Trial Phases
2 Phases
Phase 1:2
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)โข Click on a phase to view related trials
Phase 1
2 (66.7%)Phase 4
1 (33.3%)Drug Interactions Between Dolutegravir and Escalating Doses of Rifampicin
- First Posted Date
- 2019-11-18
- Last Posted Date
- 2024-08-13
- Lead Sponsor
- Helen Reynolds
- Target Recruit Count
- 36
- Registration Number
- NCT04166474
- Locations
- ๐ฟ๐ฆ
Desmond Tutu Health Foundation, Cape Town, South Africa
๐บ๐ฌInfectious Diseases Institute, Kampala, Uganda
Validation of Drug Assays in Various Biological Matrices
Recruiting
- Conditions
- Infection
- First Posted Date
- 2014-11-05
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- Helen Reynolds
- Target Recruit Count
- 100
- Registration Number
- NCT02283112
- Locations
- ๐ฌ๐ง
Royal Liverpool & Broadgreen Univeristy Hospitals NHS Trust, Liverpool, United Kingdom
The Effect of Antacids and Multivitamins on Raltegravir
Phase 1
Completed
- Conditions
- HIV
- Interventions
- Drug: Maalox Plus extraDietary Supplement: MultivitaminsDietary Supplement: Sodium bicarbonate
- First Posted Date
- 2013-02-05
- Last Posted Date
- 2016-02-25
- Lead Sponsor
- Helen Reynolds
- Target Recruit Count
- 15
- Registration Number
- NCT01784302
- Locations
- ๐ฌ๐ง
Royal Liverpool University Hospital, Liverpool, United Kingdom
The Effect of Intermittent Rifampicin on Raltegravir
Phase 1
Completed
- Conditions
- HIVTuberculosis
- First Posted Date
- 2011-08-29
- Last Posted Date
- 2013-10-31
- Lead Sponsor
- Helen Reynolds
- Target Recruit Count
- 18
- Registration Number
- NCT01424826
- Locations
- ๐ฌ๐ง
Royal Liverpool & Broadgreen Univeristy Hospitals NHS Trust, Liverpool, United Kingdom
News
No news found